British Journal of Pharmacology and Chemotherapy · 1961 · 11 citations · 7 references
PharmacyPharmacokineticsPharmacologyBioavailabilityDrug MetabolismRenal PharmacokineticsDrug DispositionDrug ExcretionPharmacokinetics Of AntimicrobialsRenal Drug AbsorptionRenal Drug ClearanceRenal Drug DistributionMethicillin ResistancePenicillin ResistancePharmacokinetics Of Antimicrobial AgentsRenal Tubular SecretionResistance Mechanisms In Staphylococci
The pharmacology of a new antibiotic methicillin, 6(2:6-dimethoxybenzamido)-penicillanic acid, which is effective against staphylococci resistant to penicillin G, has been investigated. It is free from acute and chronic toxic effects, except that some pain may be caused following intramuscular injection. It is poorly absorbed orally, but after intramuscular injection the concentrations in the serum and in tissues are very similar to those found with penicillin G. It is excreted by the kidneys both by renal tubular secretion and glomerular filtration. It is also excreted in the bile in very high concentrations, the ratio of concentration in the bile to the blood being approximately 2.5 times that of penicillin G. From a study of the metabolism of the drug it is calculated that 75% is eliminated unchanged in the urine and that the remainder is probably destroyed after the excretion into the intestine via the bile.
7
Synthesis of Penicillin: 6-Aminopenicillanic Acid in Penicillin Fermentations
F. R. Batchelor, F. P. Doyle, J. H. C. Nayler et al. · Nature · 1959 · 389 citations
A New Penicillin (BRL 1241) Active Against Penicillin-resistant Staphylococci
Robert Knox · BMJ · 1960 · 67 citations · Full text
A. H. Douthwaite, J. A. P. Trafford · BMJ · 1960 · 40 citations · Full text
Report on Clinical Use of BRL 1241 in Children with Staphylococcal and Streptococcal Infections
Gordon T. Stewart, H.H. Nixon, Hannah Coles et al. · BMJ · 1960 · 37 citations · Full text